Table 3—

Septic shock development in ventilator-associated pneumonia patients

Nonseptic shockSeptic shockp-value
Age yrs64.1±16.158.9±19.40.569#
Subjects2322
 Male1915
 Female47
Survivors1712
Nonsurvivors610
APACHE II13.0 (7.0–15.0)13.0 (10.5–16.5)0.340#
SOFA D13.0 (2.0–3.0)6.5 (3.0–8.0)<0.001
CRP D112.4 (5.7–20.1)19.7 (17.2–31.7)0.001
PCT D10.37 (0.22–0.48)0.55 (0.30–2.46)0.001
SOFA D43.0 (2.0–4.0)8.0 (6.0–9.0)<0.001
CRP D414.6 (6.3–32.2)19.8 (14.5–29.8)0.163#
PCT D40.41 (0.32–0.47)0.56 (0.49–1.67)0.005
SOFA D72.0 (2.0–3.0)8.0 (6.0–9.25)<0.001
CRP D79.3 (6.0–24.8)18.6 (17.6–26.6)0.002
PCT D70.43 (0.35–1.13)0.72 (0.39–2.58)0.159#
Microbiological culture
 Endotracheal aspirate2017
 Bronchoscopic material35
  • Data are presented as mean±sd, n or median (interquartile range 25–75th percentile), unless stated otherwise. Values in bold are statistically significant. APACHE II: Acute Physiology and Chronic Health Evaluation II; SOFA: Sequential Organ Failure Assessment; D: day; CRP: C-reactive protein; PCT: procalcitonin. #: nonsignificant.